![Brian Schwartz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Schwartz
Plus aucun poste en cours
Profil
Brian D.
Schwartz formerly worked at Infinity Pharmaceuticals, Inc., as Director from 2021 to 2023, Mereo BioPharma Group Plc, as Director from 2020 to 2022, LifeSci Acquisition Corp., as Independent Director in 2020, Enlivex Therapeutics Ltd., as Director from 2020 to 2025, ArQule, Inc., as Chief Medical Officer, Head-Research & Development from 2008 to 2020, Alaunos Therapeutics, Inc., as Chief Medical Officer, Intensity Therapeutics, Inc., as Executive VP-Clinical Development, and Cyclacel Pharmaceuticals, Inc., as Chief Medical Officer in 2025.
Dr. Schwartz received his doctorate degree in 1985 from the University of Pretoria.
Anciens postes connus de Brian Schwartz
| Sociétés | Poste | Fin |
|---|---|---|
| ENLIVEX | Directeur/Membre du Conseil | 04/01/2025 |
| BIO GREEN MED SOLUTION, INC. | Directeur Technique/Scientifique/R&D | 04/01/2025 |
| INTENSITY THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 04/01/2025 |
| INFINITY PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 10/11/2022 |
Formation de Brian Schwartz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Pretoria
 University of Pretoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
